Erythropoietins in cancer patients: ESMO Recommendations for use
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2007-05, Vol.18 (suppl-2), p.ii86-ii88 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | ii88 |
|---|---|
| container_issue | suppl-2 |
| container_start_page | ii86 |
| container_title | Annals of oncology |
| container_volume | 18 |
| creator | Greil, R Thödtmann, R |
| description | |
| doi_str_mv | 10.1093/annonc/mdm051 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70484091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdm051</oup_id><sourcerecordid>70484091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-a9ed5d9c75b229e29a649949a5ccc2d1d83eda94909aabd6fb5f12455a8195493</originalsourceid><addsrcrecordid>eNqF0M9L3EAUB_BBLO5qe_RagofSS9z5nTxPtsvaLbgK7QriZZidmdDYzUycScD97xvJYsGLpwePD9_3-CJ0SvA5wcBm2vvgzayxDRbkAE2JkJCXmJNDNMVAWV4IxifoOKVHjLEECkdoQgoOBEs6RZeLuOv-xNCG2nW1T1ntM6O9cTFrdVc736WLbPF7dZv9ciY0jfN2WIcBViFmfXIf0YdKb5P7tJ8n6O5qsZ4v8-vbHz_n365zw2nZ5RqcFRZMITaUgqOgJQfgoIUxhlpiS-asHhYYtN5YWW1ERSgXQpcEBAd2gr6MuW0MT71LnWrqZNx2q70LfVIF5iXHQAZ49gY-hj764TdFQEpeEPaC8hGZGFKKrlJtrBsdd4pg9dKrGntVY6-D_7wP7TeNs__1vsgBfB1B6Nt3s_a369S551es418lC1YItbx_UDdXcj1nbKW-s39vU5G-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>196647131</pqid></control><display><type>article</type><title>Erythropoietins in cancer patients: ESMO Recommendations for use</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Greil, R ; Thödtmann, R</creator><creatorcontrib>Greil, R ; Thödtmann, R ; ESMO Guidelines Working Group</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdm051</identifier><identifier>PMID: 17491062</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Anemia - drug therapy ; Anemia - etiology ; Blood Transfusion ; Economics, Pharmaceutical ; Erythropoietin - administration & dosage ; Erythropoietin - adverse effects ; Erythropoietin - economics ; Humans ; Iron - administration & dosage ; Neoplasms - complications ; Neoplasms - drug therapy ; Quality of Life ; Treatment Outcome</subject><ispartof>Annals of oncology, 2007-05, Vol.18 (suppl-2), p.ii86-ii88</ispartof><rights>2007 European Society for Medical Oncology 2006</rights><rights>2007 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-a9ed5d9c75b229e29a649949a5ccc2d1d83eda94909aabd6fb5f12455a8195493</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17491062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Greil, R</creatorcontrib><creatorcontrib>Thödtmann, R</creatorcontrib><creatorcontrib>ESMO Guidelines Working Group</creatorcontrib><title>Erythropoietins in cancer patients: ESMO Recommendations for use</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><subject>Anemia - drug therapy</subject><subject>Anemia - etiology</subject><subject>Blood Transfusion</subject><subject>Economics, Pharmaceutical</subject><subject>Erythropoietin - administration & dosage</subject><subject>Erythropoietin - adverse effects</subject><subject>Erythropoietin - economics</subject><subject>Humans</subject><subject>Iron - administration & dosage</subject><subject>Neoplasms - complications</subject><subject>Neoplasms - drug therapy</subject><subject>Quality of Life</subject><subject>Treatment Outcome</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0M9L3EAUB_BBLO5qe_RagofSS9z5nTxPtsvaLbgK7QriZZidmdDYzUycScD97xvJYsGLpwePD9_3-CJ0SvA5wcBm2vvgzayxDRbkAE2JkJCXmJNDNMVAWV4IxifoOKVHjLEECkdoQgoOBEs6RZeLuOv-xNCG2nW1T1ntM6O9cTFrdVc736WLbPF7dZv9ciY0jfN2WIcBViFmfXIf0YdKb5P7tJ8n6O5qsZ4v8-vbHz_n365zw2nZ5RqcFRZMITaUgqOgJQfgoIUxhlpiS-asHhYYtN5YWW1ERSgXQpcEBAd2gr6MuW0MT71LnWrqZNx2q70LfVIF5iXHQAZ49gY-hj764TdFQEpeEPaC8hGZGFKKrlJtrBsdd4pg9dKrGntVY6-D_7wP7TeNs__1vsgBfB1B6Nt3s_a369S551es418lC1YItbx_UDdXcj1nbKW-s39vU5G-</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Greil, R</creator><creator>Thödtmann, R</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>Erythropoietins in cancer patients: ESMO Recommendations for use</title><author>Greil, R ; Thödtmann, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-a9ed5d9c75b229e29a649949a5ccc2d1d83eda94909aabd6fb5f12455a8195493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Anemia - drug therapy</topic><topic>Anemia - etiology</topic><topic>Blood Transfusion</topic><topic>Economics, Pharmaceutical</topic><topic>Erythropoietin - administration & dosage</topic><topic>Erythropoietin - adverse effects</topic><topic>Erythropoietin - economics</topic><topic>Humans</topic><topic>Iron - administration & dosage</topic><topic>Neoplasms - complications</topic><topic>Neoplasms - drug therapy</topic><topic>Quality of Life</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Greil, R</creatorcontrib><creatorcontrib>Thödtmann, R</creatorcontrib><creatorcontrib>ESMO Guidelines Working Group</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Greil, R</au><au>Thödtmann, R</au><aucorp>ESMO Guidelines Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erythropoietins in cancer patients: ESMO Recommendations for use</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>18</volume><issue>suppl-2</issue><spage>ii86</spage><epage>ii88</epage><pages>ii86-ii88</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>17491062</pmid><doi>10.1093/annonc/mdm051</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2007-05, Vol.18 (suppl-2), p.ii86-ii88 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70484091 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Anemia - drug therapy Anemia - etiology Blood Transfusion Economics, Pharmaceutical Erythropoietin - administration & dosage Erythropoietin - adverse effects Erythropoietin - economics Humans Iron - administration & dosage Neoplasms - complications Neoplasms - drug therapy Quality of Life Treatment Outcome |
| title | Erythropoietins in cancer patients: ESMO Recommendations for use |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T02%3A22%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erythropoietins%20in%20cancer%20patients:%20ESMO%20Recommendations%20for%20use&rft.jtitle=Annals%20of%20oncology&rft.au=Greil,%20R&rft.aucorp=ESMO%20Guidelines%20Working%20Group&rft.date=2007-05-01&rft.volume=18&rft.issue=suppl-2&rft.spage=ii86&rft.epage=ii88&rft.pages=ii86-ii88&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdm051&rft_dat=%3Cproquest_cross%3E70484091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=196647131&rft_id=info:pmid/17491062&rft_oup_id=10.1093/annonc/mdm051&rfr_iscdi=true |